Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by alleyesonmeon Dec 19, 2024 4:55pm
107 Views
Post# 36371095

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Back channel happenings. Agree!, to many quincedents, oddities, all roads lead to a takeover..no majority shareholder, no institutional investments...This Corp has been trading at a valuation of 30-40m for years..when the market doesn't give, other corporations do by means of a takeout...Barrie is the only facility in Canada FDA certified for camnabinoids..hence numerous partnerships...Jazz could buy, manufacture epidiolex immediately, without delay..feed the growing sales, indications for use...at the same time setting generic production back a few years...how would Labs "global pharmaceutical ANDA partner react to this?..bidding war anyone?...considering Jazz spent 100m for expansion to the U.K production facility..having a turnkey operation in North America is very compelling ..obviously execs will happily endorse a good offer, collectively they amended to accelerate 8m RSU (free shares for themselves) by 13 days...(perplexing outside of the context of protecting from takeover terms).. Pidduck alone owns more than 18m shares...the current valuation given on the market puts a target on MPLs back along with countless other reasons...I think the darts been thrown....and nice point on the disclosure of land sale intentions..nothing on facility....how about this trading..manipulation much! 
<< Previous
Bullboard Posts
Next >>